Advertisement
NEW YORK, Jan. 30, 2019 /PRNewswire-PRWeb/ -- The Conference Forum announced an event to help hospital systems and the pharma industry to integrate programs to give patients the choice of a clinical trial as a care option. The conference, known as CRAACO will take place on April 28-29, 2019 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.
"For patients in need of a clinical trial, the burden is usually on them to find one as most physicians don't have the resources or time to locate a trial for their patients", said Valerie Bowling, Executive Director, the Conference Forum.
CRAACO will bring a variety of health systems from across the nation together with pharma and biotech companies, patient advocacy, payors, regulators, and innovators to chart a path forward integrating clinical care with clinical research options. "We recognize that there is no gold standard to forging this integration, but there is interest and desire to get started. Our goal is to present case studies and examples of those who have begun this journey and demonstrate the tools needed to bridge the gaps between pharma and healthcare", said Allyson Adams, Conference Producer of CRAACO.
The program will kick off with co-chairs Jeff James, CEO, Wilmington Health and Sarah Larson, Cancer Veteran and Director of Global Clinical Operations, Biogen on identifying treatment gaps for patients.
The speaking faculty will address the goals for care vs research, patient and provider input on the goals and challenges they are facing. The program will assess the operational barriers to integration.
UCSF Carol Franc Buck Breast Care Center notable surgeon, Dr Laura Esserman will delivery a keynote on integrating clinical care and clinical research. She will present the I-SPY 2 TRIAL™ as a case study clinical trial on improving the outcomes of early stage, breast cancer for patients who are at high risk for early recurrence, which would not be possible without the integration of care and research.
Other case studies will include Sanford Health System's astonishing growth from offering 3% of patients clinical trials to 10% within the last 8 years and a presentation from the Medical Center for Interoperability on building an interoperable data network to make patients the brokers of their own data.
The conference will continue on day two with discussions of operational barriers, the tools needed to start implementing clinical research initiatives, creating more awareness and understanding of clinical trials, and the role of pharma collaborations with healthcare. Consortia from Philadelphia, El Paso, and Chicago will present how they are building infrastructures for the integration of care and clinical research to serve their respective geographic regions.
To learn more about the CRAACO conference, click here.
About Clinical Research as a Care Option: Clinical Research as a Care Option (CRAACO) is a strategic collaborative event bringing together a variety of health systems, pharma, patient advocacy, payors, regulators, and innovators to chart a path forward integrating clinical care with clinical research options. With four years of experience gathering the clinical research and healthcare communities together, CRAACO has the most experience addressing the value, opportunities, and challenges to integrating clinical research as a care option for patients.
About the Conference Forum: The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.
SOURCE Clinical Research as a Care Option
Advertisement
"For patients in need of a clinical trial, the burden is usually on them to find one as most physicians don't have the resources or time to locate a trial for their patients", said Valerie Bowling, Executive Director, the Conference Forum.
CRAACO will bring a variety of health systems from across the nation together with pharma and biotech companies, patient advocacy, payors, regulators, and innovators to chart a path forward integrating clinical care with clinical research options. "We recognize that there is no gold standard to forging this integration, but there is interest and desire to get started. Our goal is to present case studies and examples of those who have begun this journey and demonstrate the tools needed to bridge the gaps between pharma and healthcare", said Allyson Adams, Conference Producer of CRAACO.
The program will kick off with co-chairs Jeff James, CEO, Wilmington Health and Sarah Larson, Cancer Veteran and Director of Global Clinical Operations, Biogen on identifying treatment gaps for patients.
The speaking faculty will address the goals for care vs research, patient and provider input on the goals and challenges they are facing. The program will assess the operational barriers to integration.
UCSF Carol Franc Buck Breast Care Center notable surgeon, Dr Laura Esserman will delivery a keynote on integrating clinical care and clinical research. She will present the I-SPY 2 TRIAL™ as a case study clinical trial on improving the outcomes of early stage, breast cancer for patients who are at high risk for early recurrence, which would not be possible without the integration of care and research.
Other case studies will include Sanford Health System's astonishing growth from offering 3% of patients clinical trials to 10% within the last 8 years and a presentation from the Medical Center for Interoperability on building an interoperable data network to make patients the brokers of their own data.
The conference will continue on day two with discussions of operational barriers, the tools needed to start implementing clinical research initiatives, creating more awareness and understanding of clinical trials, and the role of pharma collaborations with healthcare. Consortia from Philadelphia, El Paso, and Chicago will present how they are building infrastructures for the integration of care and clinical research to serve their respective geographic regions.
To learn more about the CRAACO conference, click here.
About Clinical Research as a Care Option: Clinical Research as a Care Option (CRAACO) is a strategic collaborative event bringing together a variety of health systems, pharma, patient advocacy, payors, regulators, and innovators to chart a path forward integrating clinical care with clinical research options. With four years of experience gathering the clinical research and healthcare communities together, CRAACO has the most experience addressing the value, opportunities, and challenges to integrating clinical research as a care option for patients.
About the Conference Forum: The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.
SOURCE Clinical Research as a Care Option
